These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 2824706

  • 21. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E, Silvano G, Tibaldi C, Campoccia S, Cionini L, Conte P.
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [Abstract] [Full Text] [Related]

  • 22. Docetaxel consolidation therapy following cisplatin, vinorelbine, and concurrent thoracic radiotherapy in patients with unresectable stage III non-small cell lung cancer.
    Sekine I, Nokihara H, Sumi M, Saijo N, Nishiwaki Y, Ishikura S, Mori K, Tsukiyama I, Tamura T.
    J Thorac Oncol; 2006 Oct; 1(8):810-5. PubMed ID: 17409964
    [Abstract] [Full Text] [Related]

  • 23. Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic non-small cell lung cancer.
    Thongprasert S, Chewaskulyong B.
    J Med Assoc Thai; 2004 Oct; 87(10):1162-7. PubMed ID: 15560691
    [Abstract] [Full Text] [Related]

  • 24. Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
    Giaccone G, Splinter TA, Debruyne C, Kho GS, Lianes P, van Zandwijk N, Pennucci MC, Scagliotti G, van Meerbeeck J, van Hoesel Q, Curran D, Sahmoud T, Postmus PE.
    J Clin Oncol; 1998 Jun; 16(6):2133-41. PubMed ID: 9626213
    [Abstract] [Full Text] [Related]

  • 25. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Souquet PJ, Fournel P, Bohas CH, Fortune IC, Chatte G.
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239
    [Abstract] [Full Text] [Related]

  • 26. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P, Herndon J, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ.
    Cancer; 1996 Jun 01; 77(11):2393-9. PubMed ID: 8635112
    [Abstract] [Full Text] [Related]

  • 27. Symptomatic, stage IV, non-small-cell lung cancer (NSCLC): response, toxicity, performance status change and symptom relief in patients treated with cisplatin, vinblastine and mitomycin-C.
    Tummarello D, Graziano F, Isidori P, Cellerino R.
    Cancer Chemother Pharmacol; 1995 Jun 01; 35(3):249-53. PubMed ID: 7528646
    [Abstract] [Full Text] [Related]

  • 28. Neoadjuvant cisplatin plus vinblastine chemotherapy in locally advanced non-small cell lung cancer.
    Johnson DH, Strupp J, Greco FA, Stewart J, Merrill W, Malcolm A, Hande KR, Hainsworth JD.
    Cancer; 1991 Sep 15; 68(6):1216-20. PubMed ID: 1651802
    [Abstract] [Full Text] [Related]

  • 29. Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study.
    Frasci G, Comella P, Scoppa G, Guida C, Gravina A, Fiore F, Casaretti R, Daponte A, Parziale A, Comella G.
    J Clin Oncol; 1997 Apr 15; 15(4):1409-17. PubMed ID: 9193333
    [Abstract] [Full Text] [Related]

  • 30. [Optimization of combined radiotherapy and chemotherapy in treatment of non-small cell lung carcinoma].
    Bretel JJ, Arriagada R, Le Chevalier T, Baldeyrou P, Grunenwald D, Le Péchoux C, Pellae-Cosset B, Ruffié P.
    Cancer Radiother; 1997 Apr 15; 1(2):148-53. PubMed ID: 9273186
    [Abstract] [Full Text] [Related]

  • 31. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.
    Lena MD, Ramlau R, Hansen O, Lorusso V, Wagner L, Barni S, Cristovao MM, Huber R, Alberola V, Mitrovic M, Colin C, Gasmi J.
    Lung Cancer; 2005 Apr 15; 48(1):129-35. PubMed ID: 15777980
    [Abstract] [Full Text] [Related]

  • 32. Cisplatin, vinblastine, and mitoguazone chemotherapy for epidermoid and adenocarcinoma of the esophagus.
    Forastiere AA, Gennis M, Orringer MB, Agha FP.
    J Clin Oncol; 1987 Aug 15; 5(8):1143-9. PubMed ID: 3625244
    [Abstract] [Full Text] [Related]

  • 33. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
    Langer CJ, Movsas B, Hudes R, Schol J, Keenan E, Kilpatrick D, Yeung C, Curran W.
    Semin Oncol; 1997 Aug 15; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
    [Abstract] [Full Text] [Related]

  • 34. Combined treatment with chemotherapy and neutron irradiation for limited non-small-cell lung cancer: a Southwest Oncology Group Study.
    Livingston RB, Griffin BR, Higano CS, Laramore GE, Rivkin SE, Goldberg RS, Schulman SF.
    J Clin Oncol; 1987 Nov 15; 5(11):1716-24. PubMed ID: 2824705
    [Abstract] [Full Text] [Related]

  • 35. A phase I/II trial of neoadjuvant chemotherapy with cisplatin and vinorelbine followed by accelerated irradiation for patients with inoperable nonsmall cell lung carcinoma.
    Viallet J, Brassard MA, Souhami L, Ayoub J, Del Vecchio P, Kreisman H, Guerra J, Gruber J, Langleben A, Hohneker J, Rousseau P.
    Cancer; 1999 Jun 15; 85(12):2562-9. PubMed ID: 10375103
    [Abstract] [Full Text] [Related]

  • 36. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer.
    Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, Carey RW, Frei EF, Green MR.
    N Engl J Med; 1990 Oct 04; 323(14):940-5. PubMed ID: 2169587
    [Abstract] [Full Text] [Related]

  • 37. Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer. A phase II trial conducted by the Groupe Francais de Pneumo-Cancerologie (GFPC).
    Vergnenègre A, Daniel C, Léna H, Fournel P, Kleisbauer JP, Le Caer H, Letreut J, Paillotin D, Pérol M, Bouchaert E, Preux PM, Robinet G, Groupe Francais de Pneumo-Cancerologie.
    Lung Cancer; 2005 Mar 04; 47(3):395-404. PubMed ID: 15713523
    [Abstract] [Full Text] [Related]

  • 38. Duration of chemotherapy in advanced non-small-cell lung cancer: a randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin.
    Smith IE, O'Brien ME, Talbot DC, Nicolson MC, Mansi JL, Hickish TF, Norton A, Ashley S.
    J Clin Oncol; 2001 Mar 01; 19(5):1336-43. PubMed ID: 11230476
    [Abstract] [Full Text] [Related]

  • 39. Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer. Final results of a multicenter phase II study.
    Cigolari S, Curcio C, Maiorino A, Sessa R, Cioffi A, Massimo M.
    Anticancer Res; 2003 Mar 01; 23(2C):1803-9. PubMed ID: 12820462
    [Abstract] [Full Text] [Related]

  • 40. Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer.
    Ellis PA, Smith IE, Hardy JR, Nicolson MC, Talbot DC, Ashley SE, Priest K.
    Br J Cancer; 1995 Feb 01; 71(2):366-70. PubMed ID: 7530988
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.